Related Experiment Video
Updated: Jul 9, 2026
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
cDNA microarray analysis of the differentially expressed genes involved in murine pre-osteoclast RAW264.7 cells
Qi Zhang1, Chi-Chun Fong, Yaou Zhang
1Department of Biology and Chemistry, City University of Hong Kong, Kowloon, Hong Kong, China.
Abstract:
Glucocorticoids (GCs) are hormones with anti-inflammatory and immuno-suppressive effects. The use of hormonal medicine like GCs may cause systemic adverse effects. In the present study, the cellular response of murine pre-osteoclast cell line RAW264.7 to dexamethasone (DEX) was investigated and the result demonstrated that DEX may stimulate RAW264.7 cells proliferation. Changes in gene expression involved in RAW264.7 cells proliferation stimulated by dexamethasone were investigated using cDNA microarrays containing 1000 cDNAs. It was found that 67 genes were regulated by DEX and could be grouped into 8 functional categories, including cell cycle regulation, cell survival, metabolism, pro-inflammatory effect, cytoskeleton, proteasome, signaling transduction and transcription factors. Moreover, some signaling pathways that involve in modulation of DEX on RAW264.7 cells functions were identified, including p53, 14-3-3 gamma, MAPK, Elk-1, I kappa B and Ifn related pathways.
Insights
Dexamethasone (DEX) may stimulate the proliferation of murine pre-osteoclast cells (RAW264.7). This study identified 67 genes and key signaling pathways involved in DEX-induced cell growth, offering insights into glucocorticoid cellular responses.
Area of Science:
- Cell Biology
- Pharmacology
- Molecular Biology
Background:
- Glucocorticoids (GCs) are potent anti-inflammatory and immunosuppressive hormones.
- Systemic use of GCs can lead to adverse effects.
- Understanding cellular responses to GCs is crucial for therapeutic applications.
Purpose of the Study:
- To investigate the cellular response of murine pre-osteoclast cell line RAW264.7 to dexamethasone (DEX).
- To identify genes and signaling pathways modulated by DEX in RAW264.7 cells.
Main Methods:
- Murine pre-osteoclast cell line RAW264.7 was treated with dexamethasone (DEX).
- Cellular proliferation was assessed.
- Gene expression changes were analyzed using cDNA microarrays (1000 cDNAs).
- Signaling pathways were identified.
Main Results:
- DEX was found to stimulate RAW264.7 cell proliferation.
- A total of 67 genes were regulated by DEX.
- Regulated genes were categorized into 8 functional groups: cell cycle, cell survival, metabolism, pro-inflammatory effect, cytoskeleton, proteasome, signaling transduction, and transcription factors.
- Key signaling pathways modulated by DEX include p53, 14-3-3 gamma, MAPK, Elk-1, I kappa B, and Ifn pathways.
Conclusions:
- Dexamethasone stimulates proliferation in RAW264.7 pre-osteoclast cells.
- DEX modulates a wide range of cellular functions through gene expression changes.
- Identified signaling pathways provide targets for understanding DEX's effects on osteoclast biology.
